Objectives, Budgets, Thresholds, and Opportunity Costs-A Health Economics Approach: An ISPOR Special Task Force Report [4]

被引:41
|
作者
Danzon, Patricia M. [1 ]
Drummond, Michael F. [2 ]
Towse, Adrian [3 ]
Pauly, Mark V. [1 ]
机构
[1] Univ Penn, Wharton Sch, Hlth Care Management, 3641 Locust Walk, Philadelphia, PA 19104 USA
[2] Univ York, Ctr Hlth Econ, York, N Yorkshire, England
[3] Off Hlth Econ, London, England
关键词
budgets; cost-effectiveness; opportunity cost; thresholds;
D O I
10.1016/j.jval.2017.12.008
中图分类号
F [经济];
学科分类号
02 ;
摘要
The fourth section of our Special Task Force report focuses on a health plan or payer's technology adoption or reimbursement decision, given the array of technologies, on the basis of their different values and costs. We discuss the role of budgets, thresholds, opportunity costs, and affordability in making decisions. First, we discuss the use of budgets and thresholds in private and public health plans, their interdependence, and connection to opportunity cost. Essentially, each payer should adopt a decision rule about what is good value for money given their budget; consistent use of a cost-per-quality adjusted life-year threshold will ensure the maximum health gain for the budget. In the United States, different public and private insurance programs could use different thresholds, reflecting the differing generosity of their budgets and implying different levels of access to technologies. In addition, different insurance plans could consider different additional elements to the quality-adjusted life-year metric discussed elsewhere in our Special Task Force report. We then define affordability and discuss approaches to deal with it, including consideration of disinvestment and related adjustment costs, the impact of delaying new technologies, and comparative cost effectiveness of technologies. Over time, the availability of new technologies may increase the amount that populations want to spend on health care. We then discuss potential modifiers to thresholds, including uncertainty about the evidence used in the decision-making process. This article concludes by discussing the application of these concepts in the context of the pluralistic US health care system, as well as the "excess burden" of tax-financed public programs versus private programs.
引用
收藏
页码:140 / 145
页数:6
相关论文
共 8 条
  • [1] Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3]
    Lakdawalla, Darius N.
    Doshi, Jalpa A.
    Garrison, Louis P., Jr.
    Phelps, Charles E.
    Basu, Anirban
    Danzon, Patricia M.
    [J]. VALUE IN HEALTH, 2018, 21 (02) : 131 - 139
  • [2] Approaches to Aggregation and Decision Making-A Health Economics Approach: An ISPOR Special Task Force Report [5]
    Phelps, Charles E.
    Lakdawalla, Darius N.
    Basu, Anirban
    Drummond, Michael F.
    Towse, Adrian
    Danzon, Patricia M.
    [J]. VALUE IN HEALTH, 2018, 21 (02) : 146 - 154
  • [3] Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6]
    Willke, Richard J.
    Neumann, Peter J.
    Garrison, Louis P., Jr.
    Ramsey, Scott D.
    [J]. VALUE IN HEALTH, 2018, 21 (02) : 155 - 160
  • [4] A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1]
    Neumann, Peter J.
    Willke, Richard J.
    Garrison, LouisP., Jr.
    [J]. VALUE IN HEALTH, 2018, 21 (02) : 119 - 123
  • [5] An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2]
    Garrison, Louis P., Jr.
    Pauly, Mark V.
    Willke, Richard J.
    Neumann, Peter J.
    [J]. VALUE IN HEALTH, 2018, 21 (02) : 124 - 130
  • [6] A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7]
    Garrison, Louis P., Jr.
    Neumann, Peter J.
    Willke, Richard J.
    Basu, Anirban
    Danzon, Patricia M.
    Doshi, Jalpa A.
    Drummond, Michael F.
    Lakdawalla, Darius N.
    Pauly, Mark V.
    Phelps, Charles E.
    Ramsey, Scott D.
    Towse, Adrian
    Weinstein, Milton C.
    [J]. VALUE IN HEALTH, 2018, 21 (02) : 161 - 165
  • [7] Reflections on the ISPOR Special Task Force on US Value Frameworks: Implications of a Health Economics Approach for Managed Care Pharmacy
    Garrison, Louis P., Jr.
    Neumann, Peter J.
    Willke, Richard J.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (11): : 1185 - +
  • [8] Machine Learning Methods in Health Economics and Outcomes Research-The PALISADE Checklist: A Good Practices Report of an ISPOR Task Force
    Padula, William, V
    Kreif, Noemi
    Vanness, David J.
    Adamson, Blythe
    Rueda, Juan-David
    Felizzi, Federico
    Jonsson, Pall
    IJzerman, Maarten J.
    Butte, Atul
    Crown, William
    [J]. VALUE IN HEALTH, 2022, 25 (07) : 1063 - 1080